Leland J. Yee

机构：Gilead Sciences (United States) · ORCID：0000-0002-0369-5878

发表论文 112 篇 · 总被引 3191 次 · h-index 31

代表论文

• Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials (2024 · Alimentary Pharmacology & Therapeutics · 被引 30)
• Baseline Viral Load and On-Treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort Study (2024 · Clinical Gastroenterology and Hepatology · 被引 16)
• Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase (2024 · Journal of Viral Hepatitis · 被引 11)
• Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B (2025 · AIDS · 被引 9)
• Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment (2025 · Alimentary Pharmacology & Therapeutics · 被引 9)
• Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B (2025 · Clinical Gastroenterology and Hepatology · 被引 7)